JUN and head and neck squamous cell carcinoma: Clinically c-Jun over expression has been noted in non-small cell lung cancers (NSCLCs) [13], vulvar squamous cell carcinoma [14], colorectal cancer [15], Hodgkin lymphoma [16], and recently in HNSCC [17].